D-0135-2018 Class III Terminated

Recalled by Bayer HealthCare Pharmaceuticals, Inc. — Whippany, NJ

FDA drug recall D-0135-2018 was initiated by Bayer HealthCare Pharmaceuticals, Inc. on Nov 10, 2017 and is designated Class III. Reason for recall: Failed Stability Specifications The recall status is terminated (terminated Apr 3, 2020). Affected quantity: 104,128 HDPE bottles.

Recall details

Product Type
Drugs
Report Date
Jan 3, 2018
Initiation Date
Nov 10, 2017
Termination Date
Apr 3, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
104,128 HDPE bottles

Product description

Bayer Chewable Low Dose Aspirin 81 mg Orange Flavored 36 tablets, Made in Spain, Distributed by: Bayer Healthcare LLC Morristown, NJ 07962 NDC 0280-2160-36 UPC 3128431310577

Reason for recall

Failed Stability Specifications

Distribution pattern

Natonwide

Code information

Lot # NAA3T0X; Exp. 07/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0135-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0135-2018. Report a data issue: hello@regdatalab.com.